Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05583552
Title Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy (IMpress)
Acronym IMpress
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GCP-Service International West GmbH
Age Groups: senior | adult
Covered Countries FRA | DEU | AUS

No variant requirements are available.